Centene Corporation’s CNC subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program. The contract runs from Jan. 1, 2027, through 2030. Meridian is one of the six managed care organizations selected to provide services under the HealthChoice Illinois Medicaid program. The agreement ensures continued access to integrated primary, maternal and behavioral healthcare services for Medicaid members across Illinois.
Building on nearly 20 years of serving Illinois communities, Meridian continues to cover more than 596,000 Medicaid members. The renewal follows strong operational performance, with Meridian earning the state's highest 5-star rating on the latest HealthChoice Illinois Report Card for Access to Care, Living with Illness, and Women's and Children's Health. The agreement reinforces Centene's competitive position in the Illinois Medicaid market.
Medicaid remains Centene's largest business, with Medicaid revenues increasing 6% year over year to $23.6 billion in the first quarter of 2026. Given its heavy reliance on government-sponsored healthcare programs, the renewed Illinois contract supports premium revenue visibility and lowers the risk of future enrollment losses.
The announcement is not a game changer. It is unlikely to materially boost near-term earnings, but it preserves a significant source of premium revenues and enhances long-term earnings visibility. The renewal provides added confidence that Centene can maintain a stable Medicaid membership base and generate more predictable revenues from one of its core businesses.
How Are Competitors Faring?
Some of CNC's major competitors in the managed care space are Humana Inc. HUM and Molina Healthcare, Inc. MOH.
Humana also secured a statewide contract under Illinois' HealthChoice Illinois Medicaid program, reinforcing its presence in the state's Medicaid managed care market. The contract expands HUM's government-sponsored healthcare business and supports long-term membership growth. Even so, Medicaid is not as significant an earnings driver for HUM as it is for Centene.
Molina Healthcare relies heavily on state Medicaid contracts, which are a key driver of membership and premium revenues. MOH depends on retaining and expanding these contracts to sustain growth and earnings visibility. Continued success in state Medicaid procurements strengthens MOH's competitive position and supports long-term revenue stability.
Centene’s Price Performance, Valuation & Estimates
Shares of CNC have rallied 64.3% in the year-to-date period compared with the industry’s growth of 28.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.09, below the industry average of 18.5. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period’s level.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Centene Corporation (CNC): Free Stock Analysis Report
Humana Inc. (HUM): Free Stock Analysis Report
Molina Healthcare, Inc (MOH): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).